Clinical Trial Update: Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated whether amantadine can reduce prolactin elevations in patients treated with risperidone long-acting injectable or paliperidone; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• INVEGA SUSTENNA (PALIPERIDONE PALMITATE)
• Risperdal Consta (risperidone long-acting injectable)
• amantadine (amantadine)

Snippet

Sponsor: David C. Henderson, MD | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: TERMINATED | Results posted: 2013-06-10